Surgeons need to be aware that robotic pancreaticoduodenectomy (RPD) initially carries higher mortality risks compared to open procedures. 30-day mortality for RPD is 2.7%, compared to 2.0% for open pancreaticoduodenectomy (adjusted relative risk 1.43, p = 0.029). Mortality risk significantly decreases with surgeon experience: 0.92% for those with 19-71 RPD cases (Q5) versus 3.9% for […]

Tracking CA19-9 levels after pancreatic cancer resection can better guide surgical prognostication and patient outcomes. Patients with normalized CA19-9 levels post-surgery had a median time-to-treatment failure of 693 days, while those with persistent elevation faced just 138 days. Neoadjuvant therapy patients presented with much higher pre-treatment CA19-9 (273 u/ml) compared to surgery-first patients (19 u/ml). […]

Minimally invasive pancreatoduodenectomy (mipd) enhances recovery compared to open pancreatoduodenectomy (opd), especially in the month post-surgery. On postoperative day 30, mipd patients averaged 659 more steps and 22 more active minutes daily than those in the opd group. Mipd patients had a 9-millisecond higher heart rate variability, indicating less physiological stress. These early recovery benefits […]

Minimally invasive robotic placement of hepatic artery infusion pumps shows promise for recurrent colorectal liver metastasis patients post-hemihepatectomy. Operative time was 150 minutes with 75 ml blood loss. Patient discharge occurred on day 3 with no complications. Surgeons can consider this technique to enhance patient recovery while maintaining safety. Postoperative scans confirmed optimal hepatic perfusion […]

Neoadjuvant chemotherapy’s benefit in early-stage pancreatic ductal adenocarcinoma is questionable due to bias in survival estimates. In a study of 13,466 patients, those receiving neoadjuvant chemotherapy showed initially longer median survival (33.4 vs. 25.7 months) but this disappeared after correcting for immortal time bias. Three robust statistical methods revealed no significant survival advantage for neoadjuvant […]

Laparoscopic anterior-approach right posterior sectionectomy is a safe option for hepatocellular carcinoma tumors over 10 cm. Four patients with median tumor size of 11.5 cm underwent the procedure; all had negative margins. Median operative time was 524 minutes with minimal blood loss (80 ml) and no transfusions. This technique allows for secure transection without the […]

Surgeons can safely perform a remnant-sparing distal pancreatectomy using fluorescence guidance for select patients with metachronous pancreatic cancer after Whipple procedure. The procedure was completed in 123 minutes with only 20 ml of blood loss. Post-op, the patient had a normal amylase level and was discharged by day 5 with no complications. This approach preserves […]

Surgeons now have a validated definition of a textbook outcome for distal pancreatectomy, which influences patient selection and post-operative management. Textbook outcomes include no readmissions or deaths within 90 days, length of stay below the 75th percentile, no major complications, and negative margins. In a study of 339 patients, only 46.3% achieved this outcome; major […]

Robotic pancreatoduodenectomy has greater postoperative complication risks than laparoscopic, especially after conversion. Major morbidity rates are 49% in robotic (rpd) versus 31% in laparoscopic (lpd) after conversion (p=0.021). Conversion required in 12% of cases, with no significant difference between robotic (12%) and laparoscopic (14%). Surgeons should assess conversion risks when choosing robotic methods, emphasizing structured […]